On the public citation graph
Preclinical Characterization of the Distribution, Catabolism, and Elimination of a Polatuzumab Vedotin-Piiq (POLIVY®) Antibody–Drug Conjugate in Sprague Dawley Rats
0 signed · 56 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/jcph.116openalex-snapshot
CYP3A-Mediated Drug-Drug Interaction Potential and Excretion of Brentuximab Vedotin, an Antibody−Drug Conjugate, in Patients With CD30-Positive Hematologic Malignancies
inferredcites →https://doi.org/10.1007/s11095-015-1657-7openalex-snapshot
Current ADC Linker Chemistry
inferredcites →https://doi.org/10.1016/j.yrtph.2016.10.012openalex-snapshot
Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinic
inferredcites →https://doi.org/10.1016/s1470-2045(16)30030-4openalex-snapshot
Antibody–drug conjugates for cancer therapy
inferredcites →https://doi.org/10.1021/bc200212aopenalex-snapshot
Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats
inferredcites →https://doi.org/10.1038/nbt832openalex-snapshot
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
inferredcites →https://doi.org/10.1080/19420862.2019.1622940openalex-snapshot
Production, characterization, andin vivohalf-life extension of polymeric IgA molecules in mice
inferredcites →https://doi.org/10.1111/bph.14784openalex-snapshot
Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin
inferredcites →https://doi.org/10.1158/0008-5472.can-08-2250openalex-snapshot
Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
inferredcites →https://doi.org/10.1182/blood-2009-02-205500openalex-snapshot
Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma
inferredcites →https://doi.org/10.1208/s12248-012-9386-xopenalex-snapshot
ADME of Antibody–Maytansinoid Conjugates
inferredcites →https://doi.org/10.1517/14712598.2011.604630openalex-snapshot
Gemtuzumab ozogamicin in non-acute promyelocytic acute myeloid leukemia
inferredcites →https://doi.org/10.2147/ott.s150807openalex-snapshot
The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia
inferredcites →https://doi.org/10.2174/138920012802138598openalex-snapshot
Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism
inferredcites →https://doi.org/10.2967/jnumed.118.207753openalex-snapshot
Dual-Isotope Cryoimaging Quantitative Autoradiography: Investigating Antibody–Drug Conjugate Distribution and Payload Delivery Through Imaging
inferredcites →https://doi.org/10.2967/jnumed.118.213389openalex-snapshot
“Standing by” for Bystander Effects: Dual-Isotope Imaging of Antibody–Drug Conjugate and Payload Distribution
inferredcites →https://doi.org/10.3390/ijms17040561openalex-snapshot
Linkers Having a Crucial Role in Antibody–Drug Conjugates
inferredcites →https://doi.org/10.3390/ph13030040openalex-snapshot
2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
inferredcites →https://doi.org/10.4049/jimmunol.147.5.1548openalex-snapshot
IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts
inferredcites →https://doi.org/10.4161/mabs.3.1.13799openalex-snapshot
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/cmdc.202500262openalex-snapshot
Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
inferred← citeshttps://doi.org/10.1007/978-3-031-62007-2_12openalex-snapshot
Development of Antibody-Drug Conjugates
inferred← citeshttps://doi.org/10.1007/978-3-031-89319-3_7openalex-snapshot
Considerations for Antibody-Drug Conjugate Design: Stability and Formulation
inferred← citeshttps://doi.org/10.1007/s10928-025-09978-3openalex-snapshot
A translational physiologically-based pharmacokinetic model for MMAE-based antibody-drug conjugates
inferred← citeshttps://doi.org/10.1007/s11095-021-03162-1openalex-snapshot
Development of a Physiologically-Based Pharmacokinetic Model for Whole-Body Disposition of MMAE Containing Antibody-Drug Conjugate in Mice
inferred← citeshttps://doi.org/10.1016/j.addr.2024.115193openalex-snapshot
Clinical pharmacology strategies to accelerate the development of polatuzumab vedotin and summary of key findings
inferred← citeshttps://doi.org/10.1016/j.bmcl.2023.129573openalex-snapshot
PSMA-targeted small-molecule drug-conjugates with valine-citrulline and phosphoramidate cleavable linkers
inferred← citeshttps://doi.org/10.1016/j.dmd.2025.100103openalex-snapshot
Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of 14C-CD388 in the rat
inferred← citeshttps://doi.org/10.1016/j.gene.2024.148607openalex-snapshot
Emerging trends and therapeutic applications of monoclonal antibodies
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.124211openalex-snapshot
Antibody-Drug Conjugates: A promising breakthrough in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.lrr.2024.100467openalex-snapshot
Central nervous system relapse after combination therapy including polatuzumab vedotin in patients with diffuse large B-cell lymphoma
inferred← citeshttps://doi.org/10.1016/j.omtm.2024.101326openalex-snapshot
A novel approach to quantitate biodistribution and transduction of adeno-associated virus gene therapy using radiolabeled AAV vectors in mice
inferred← citeshttps://doi.org/10.1016/j.pharmr.2026.100117openalex-snapshot
Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs
inferred← citeshttps://doi.org/10.1016/j.taap.2023.116624openalex-snapshot
A mouse model of sensory neuropathy induced by a long course of monomethyl-auristatin E treatment
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.3c02714openalex-snapshot
DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00401openalex-snapshot
Monitoring In Vivo Performances of Protein–Drug Conjugates Using Site-Selective Dual Radiolabeling and Ex Vivo Digital Imaging
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c01861openalex-snapshot
Small Molecule-Drug Conjugates: An Emerging Drug Design Strategy for Targeted Therapeutics
inferred← citeshttps://doi.org/10.1021/jacs.4c03529openalex-snapshot
On Demand Bioorthogonal Switching of an Antibody-Conjugated SPECT Probe to a Cytotoxic Payload: from Imaging to Therapy
inferred← citeshttps://doi.org/10.1038/s41416-025-03020-6openalex-snapshot
Chemotherapy-induced neuropathy in monomethyl Auristatin E treatment: prevention by lithium
inferred← citeshttps://doi.org/10.1080/00498254.2024.2336576openalex-snapshot
A general perspective for the conduct of radiolabelled distribution, metabolism, and excretion studies for antibody-drug conjugates
inferred← citeshttps://doi.org/10.1080/00498254.2024.2345849openalex-snapshot
Monomethyl auristatin E (MMAE), a payload for multiple antibody drug conjugates (ADCs), demonstrates differential red blood cell partitioning across human and animal species
inferred← citeshttps://doi.org/10.1080/14740338.2025.2526790openalex-snapshot
Adverse event profiles of four monomethyl auristatin E-conjugated antibody drug conjugates: a disproportionality analysis based on the US FDA adverse event reporting system (FAERS) database
inferred← citeshttps://doi.org/10.1111/jcmm.18470openalex-snapshot
Immune‐related adverse events of antibody‐based biological medicines in cancer therapy
inferred← citeshttps://doi.org/10.1136/ejhpharm-2026-005172openalex-snapshot
Excreta contamination after antibody–drug conjugates administration: a systematic review and guidance for hospital pharmacists
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-22-0160openalex-snapshot
Modular Smart Molecules for PSMA-Targeted Chemotherapy
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-22-0440openalex-snapshot
Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody–Drug Conjugates
inferred← citeshttps://doi.org/10.1186/s11671-025-04303-wopenalex-snapshot
Emerging trends in synthesis, characterization, and mechanism of action of antibody-drug and antibody-nanoparticle conjugates
inferred← citeshttps://doi.org/10.21037/tbcr-21-22openalex-snapshot
A narrative review of the current landscape and future perspectives of HER2-targeting antibody drug conjugates for advanced breast cancer
inferred← citeshttps://doi.org/10.21320/2500-2139-2025-18-2-184-196openalex-snapshot
Bruton Tyrosine Kinase Inhibitors for the Treatment of Relapsed Mantle Cell Lymphoma Involving CNS: Two Case Reports and Literature Review
inferred← citeshttps://doi.org/10.22271/27891623.2025.v5.i1a.55openalex-snapshot
Impact of body image, social support, and psychological well-being on gender identity
inferred← citeshttps://doi.org/10.3389/fphar.2024.1405023openalex-snapshot
A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS)
inferred← citeshttps://doi.org/10.3390/biology10080758openalex-snapshot
Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells
inferred← citeshttps://doi.org/10.3390/molecules28237890openalex-snapshot
Introduction of Carbonyl Groups into Antibodies
inferred← citeshttps://doi.org/10.52711/0974-360x.2026.00229openalex-snapshot
A Novel LC–ESI–MS/MS Based Bioanalytical Method for Quantification of Empagliflozin in Human Plasma: Development and Validation
inferred← citeshttps://doi.org/10.5599/admet.2582openalex-snapshot
Preclinical pharmacokinetics, distribution, metabolism and excretion of disitamab vedotin
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.